当前位置： SCI文献检索 > Molecular Cancer期刊下所有文献 > Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.

Management of acquired resistance to EGFR TKI-targeted therapy in advanced non-small cell lung cancer.

Abstract：

:Recent advances in diagnosis and treatment are enabling a more targeted approach to treating lung cancers. Therapy targeting the specific oncogenic driver mutation could inhibit tumor progression and provide a favorable prognosis in clinical practice. Activating mutations of epidermal growth factor receptor (EGFR) in non-small cell lung cancer (NSCLC) are a favorable predictive factor for EGFR tyrosine kinase inhibitors (TKIs) treatment. For lung cancer patients with EGFR-exon 19 deletions or an exon 21 Leu858Arg mutation, the standard first-line treatment is first-generation (gefitinib, erlotinib), or second-generation (afatinib) TKIs. EGFR TKIs improve response rates, time to progression, and overall survival. Unfortunately, patients with EGFR mutant lung cancer develop disease progression after a median of 10 to 14 months on EGFR TKI. Different mechanisms of acquired resistance to first-generation and second-generation EGFR TKIs have been reported. Optimal treatment for the various mechanisms of acquired resistance is not yet clearly defined, except for the T790M mutation. Repeated tissue biopsy is important to explore resistance mechanisms, but it has limitations and risks. Liquid biopsy is a valid alternative to tissue re-biopsy. Osimertinib has been approved for patients with T790M-positive NSCLC with acquired resistance to EGFR TKI. For other TKI-resistant mechanisms, combination therapy may be considered. In addition, the use of immunotherapy in lung cancer treatment has evolved rapidly. Understanding and clarifying the biology of the resistance mechanisms of EGFR-mutant NSCLC could guide future drug development, leading to more precise therapy and advances in treatment.

journal_name

Mol Cancer

journal_title

Molecular cancer

authors

Wu SG,Shih JY

doi

10.1186/s12943-018-0777-1

subject

Has Abstract

pub_date

2018-02-19 00:00:00

pages

38

issue

1

issn

1476-4598

pii

10.1186/s12943-018-0777-1

journal_volume

17

pub_type

杂志文章,评审

相关文献

Molecular Cancer文献大全
  • Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes.

    abstract：BACKGROUND:MUC16 is a cell surface mucin expressed at high levels by epithelial ovarian tumors. Following proteolytic cleavage, cell surface MUC16 (csMUC16) is shed in the extracellular milieu and is detected in the serum of cancer patients as the tumor marker CA125. csMUC16 acts as an adhesion molecule and facilitates...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-118

    authors： Belisle JA,Horibata S,Jennifer GA,Petrie S,Kapur A,André S,Gabius HJ,Rancourt C,Connor J,Paulson JC,Patankar MS

    更新日期：2010-05-24 00:00:00

  • The inflammatory kinase IKKα phosphorylates and stabilizes c-Myc and enhances its activity.

    abstract：BACKGROUND:The IκB kinase (IKK) complex, comprising the two enzymes IKKα and IKKβ, is the main activator of the inflammatory transcription factor NF-κB, which is constitutively active in many cancers. While several connections between NF-κB signaling and the oncogene c-Myc have been shown, functional links between the ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-021-01308-8

    authors： Moser B,Hochreiter B,Basílio J,Gleitsmann V,Panhuber A,Pardo-Garcia A,Hoesel B,Salzmann M,Resch U,Noreen M,Schmid JA

    更新日期：2021-01-18 00:00:00

  • The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.

    abstract：BACKGROUND:Hypermethylation of promotor CpG islands is a common mechanism that inactivates tumor suppressor genes in cancer. Genes belonging to the RASSF gene family have frequently been reported as epigenetically silenced by promotor methylation in human cancers. Two members of this gene family, RASSF1A and RASSF5A ha...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-11-40

    authors： Djos A,Martinsson T,Kogner P,Carén H

    更新日期：2012-06-13 00:00:00

  • LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells.

    abstract：BACKGROUND:Expression of kappa gene is under the control of distinct cis-regulatory elements, including the kappa intron enhancer (iE kappa) and the kappa 3' enhancer (3'E kappa). The active enhancers and expression of immunoglobulin is generally considered to be restricted to B lymphocytes. However, accumulating evide...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-8-92

    authors： Liu H,Zheng H,Duan Z,Hu D,Li M,Liu S,Li Z,Deng X,Wang Z,Tang M,Shi Y,Yi W,Cao Y

    更新日期：2009-10-27 00:00:00

  • Choosing the right cell line for renal cell cancer research.

    abstract：:Cell lines are still a tool of choice for many fields of biomedical research, including oncology. Although cancer is a very complex disease, many discoveries have been made using monocultures of established cell lines. Therefore, the proper use of in vitro models is crucial to enhance our understanding of cancer. Ther...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-016-0565-8

    authors： Brodaczewska KK,Szczylik C,Fiedorowicz M,Porta C,Czarnecka AM

    更新日期：2016-12-19 00:00:00

  • Roles of Sema4D and Plexin-B1 in tumor progression.

    abstract：:Sema4D, also known as CD100, is a protein belonging to class IV semaphorin. Its physiologic roles in the immune and nervous systems have been extensively explored. However, the roles of Sema4D have extended beyond these traditionally studied territories. Via interaction with its high affinity receptor Plexin-B1, Sema4...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/1476-4598-9-251

    authors： Ch'ng ES,Kumanogoh A

    更新日期：2010-09-21 00:00:00

  • The pro-metastasis effect of circANKS1B in breast cancer.

    abstract：BACKGROUND:Recent studies indicate that circular RNA (circRNA) plays a pivotal role in cancer progression. Here, we sought to investigate its role in breast cancer. METHODS:CircANKS1B (a circRNA originated from exons 5 to 8 of the ANKS1B gene, hsa_circ_0007294) was identified by RNA-sequencing and validated by qRT-PCR...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-018-0914-x

    authors： Zeng K,He B,Yang BB,Xu T,Chen X,Xu M,Liu X,Sun H,Pan Y,Wang S

    更新日期：2018-11-19 00:00:00

  • Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines.

    abstract：BACKGROUND:An organic extract of the recreational herb khat (Catha edulis Forsk.) triggers cell death in various leukemia cell lines in vitro. The chemotherapeutics camptothecin, a plant alkaloid topoisomerase I inhibitor, was tested side-by-side with khat in a panel of acute myeloid leukemia cell lines to elucidate me...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-8-101

    authors： Bredholt T,Dimba EA,Hagland HR,Wergeland L,Skavland J,Fossan KO,Tronstad KJ,Johannessen AC,Vintermyr OK,Gjertsen BT

    更新日期：2009-11-13 00:00:00

  • The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.

    abstract：BACKGROUND:Human clear cell renal cell carcinoma (CRCC) remains resistant to therapies. Recent advances in Hypoxia Inducible Factors (HIF) molecular network led to targeted therapies, but unfortunately with only limited clinical significance. Elucidating the molecular processes involved in kidney tumorigenesis and resi...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-8-123

    authors： Dormoy V,Danilin S,Lindner V,Thomas L,Rothhut S,Coquard C,Helwig JJ,Jacqmin D,Lang H,Massfelder T

    更新日期：2009-12-16 00:00:00

  • TGFBI expression is associated with a better response to chemotherapy in NSCLC.

    abstract：BACKGROUND:Lung cancer is one of the most prevalent neoplasias in developed countries. Advances in patient survival have been limited and the identification of prognostic molecules is needed. Resistance to treatment is strongly related to tumor cell adhesion to the extracellular matrix and alterations in the quantity a...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-130

    authors： Irigoyen M,Pajares MJ,Agorreta J,Ponz-Sarvisé M,Salvo E,Lozano MD,Pío R,Gil-Bazo I,Rouzaut A

    更新日期：2010-05-28 00:00:00

  • The relevance of tyrosine kinase inhibitors for global metabolic pathways in cancer.

    abstract：:Tumor metabolism is a thrilling discipline that focuses on mechanisms used by cancer cells to earn crucial building blocks and energy to preserve growth and overcome resistance to various treatment modalities. At the same time, therapies directed specifically against aberrant signalling pathways driven by protein tyro...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-018-0798-9

    authors： Poliaková M,Aebersold DM,Zimmer Y,Medová M

    更新日期：2018-02-19 00:00:00

  • NSC114792, a novel small molecule identified through structure-based computational database screening, selectively inhibits JAK3.

    abstract：BACKGROUND:Human or animals lacking either JAK3 or the common gamma chain (gammac) expression display severe combined immunodeficiency disease, indicating the crucial role of JAK3 in T-cell development and the homeostasis of the immune system. JAK3 has also been suggested to contribute to the pathogenesis of tumorigene...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-36

    authors： Kim BH,Jee JG,Yin CH,Sandoval C,Jayabose S,Kitamura D,Bach EA,Baeg GH

    更新日期：2010-02-11 00:00:00

  • IRF5 promotes the proliferation of human thyroid cancer cells.

    abstract：BACKGROUND:Interferon Regulatory Factor 5 is a transcription factor that regulates the expression of genes involved in the response to viral infection and in the stimulation of the immune system. Moreover, multiple studies have demonstrated that it negatively regulates cell growth and oncogenesis, favoring cell differe...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-11-21

    authors： Massimino M,Vigneri P,Fallica M,Fidilio A,Aloisi A,Frasca F,Manzella L

    更新日期：2012-04-16 00:00:00

  • Hedgehog Acyltransferase as a target in estrogen receptor positive, HER2 amplified, and tamoxifen resistant breast cancer cells.

    abstract：BACKGROUND:Hedgehog acyltransferase (Hhat) catalyzes the transfer of the fatty acid palmitate onto Sonic Hedgehog (Shh), a modification that is essential for Shh signaling activity. The Shh signaling pathway has been implicated in the progression of breast cancer. METHODS:To determine the functional significance of Hh...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-015-0345-x

    authors： Matevossian A,Resh MD

    更新日期：2015-04-01 00:00:00

  • Exosomal miR-21 regulates the TETs/PTENp1/PTEN pathway to promote hepatocellular carcinoma growth.

    abstract：BACKGROUND:As an important means of communication, exosomes play an important role in the development of hepatocellular carcinoma (HCC). METHODS:Bioinformatics analysis, dual-luciferase reporter assays, methylation-specific quantitative PCR, and ChIP-PCR analysis were used to gain insight into the underlying mechanism...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-019-1075-2

    authors： Cao LQ,Yang XW,Chen YB,Zhang DW,Jiang XF,Xue P

    更新日期：2019-10-27 00:00:00

  • Correction to: Circular RNA circFGFR1 promotes progression and anti-PD-1 resistance by sponging miR-381-3p in non-small cell lung cancer cells.

    abstract：:After the publication of this work [1], an error was found in Fig. 1b. As described in the Results section that circ0084003 has 13 exons, it should be formed by 5-17 (13exons) exons, authors have described "formed by 5-19 exons". The authors extend their apology for the mistake caused by their action. With that mistak...

    journal_title：Molecular cancer

    pub_type： 已发布勘误

    doi：10.1186/s12943-020-1131-y

    authors： Zhang PF,Pei X,Li KS,Jin LN,Wang F,Wu J,Zhang XM

    更新日期：2020-02-01 00:00:00

  • Oncogenic seRNA functional activation: a novel mechanism of tumorigenesis.

    abstract：:seRNA is a noncoding RNA (ncRNA) transcribed from active super-enhancer (SE), through which SE exerts biological functions and participates in various physiological and pathological processes. seRNA recruits cofactor, RNA polymerase II and mediator to constitute and stabilize chromatin loop SE and promoter region, whi...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-020-01195-5

    authors： Tan Y,Li Y,Tang F

    更新日期：2020-04-11 00:00:00

  • Nicotine-induced survival signaling in lung cancer cells is dependent on their p53 status while its down-regulation by curcumin is independent.

    abstract：BACKGROUND:Lung cancer is the most lethal cancer and almost 90% of lung cancer is due to cigarette smoking. Even though nicotine, one of the major ingredients of cigarette smoke and the causative agent for addiction, is not a carcinogen by itself, several investigators have shown that nicotine can induce cell prolifera...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-220

    authors： Puliyappadamba VT,Cheriyan VT,Thulasidasan AK,Bava SV,Vinod BS,Prabhu PR,Varghese R,Bevin A,Venugopal S,Anto RJ

    更新日期：2010-08-20 00:00:00

  • LncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer.

    abstract：BACKGROUND:Estrogen receptor-positive (ER+) breast cancers represent approximately two-thirds of all breast cancers and have a sustained risk of late disease recurrence. Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors have shown significant efficacy in ER+ breast cancer. However, their effects are still limited by ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-020-01210-9

    authors： Jin X,Ge LP,Li DQ,Shao ZM,Di GH,Xu XE,Jiang YZ

    更新日期：2020-05-11 00:00:00

  • Circular RNA circSDHC serves as a sponge for miR-127-3p to promote the proliferation and metastasis of renal cell carcinoma via the CDKN3/E2F1 axis.

    abstract：BACKGROUND:There is increasing evidence that circular RNAs (circRNAs) have significant regulatory roles in cancer development and progression; however, the expression patterns and biological functions of circRNAs in renal cell carcinoma (RCC) remain largely elusive. METHOD:Bioinformatics methods were applied to screen...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-021-01314-w

    authors： Cen J,Liang Y,Huang Y,Pan Y,Shu G,Zheng Z,Liao X,Zhou M,Chen D,Fang Y,Chen W,Luo J,Zhang J

    更新日期：2021-01-20 00:00:00

  • Asymmetric segregation of template DNA strands in basal-like human breast cancer cell lines.

    abstract：BACKGROUND AND METHODS:Stem or progenitor cells from healthy tissues have the capacity to co-segregate their template DNA strands during mitosis. Here, we set out to test whether breast cancer cell lines also possess the ability to asymmetrically segregate their template DNA strands via non-random chromosome co-segrega...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-12-139

    authors： Liu W,Jeganathan G,Amiri S,Morgan KM,Ryan BM,Pine SR

    更新日期：2013-11-15 00:00:00

  • Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression.

    abstract：BACKGROUND:Although both circular RNAs (circRNAs) and autophagy are associated with the function of breast cancer (BC), whether circRNAs regulate BC progression via autophagy remains unknown. In this study, we aim to explore the regulatory mechanisms and the clinical significance of autophagy-associated circRNAs in BC....

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-020-01152-2

    authors： Liang G,Ling Y,Mehrpour M,Saw PE,Liu Z,Tan W,Tian Z,Zhong W,Lin W,Luo Q,Lin Q,Li Q,Zhou Y,Hamai A,Codogno P,Li J,Song E,Gong C

    更新日期：2020-03-25 00:00:00

  • Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer.

    abstract：BACKGROUND:The disruption of normal gene regulation due to microRNA dysfunction is a common event in cancer pathogenesis. MicroRNA-27b is an example of an oncogenic miRNA, and it is frequently upregulated in breast cancer. MicroRNAs have been found to deregulate tumor metabolism, which typically manifests as heightened...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-018-0851-8

    authors： Eastlack SC,Dong S,Ivan C,Alahari SK

    更新日期：2018-07-16 00:00:00

  • Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy.

    abstract：:Autophagy is a highly conserved catabolic process that mediates degradation of pernicious or dysfunctional cellular components, such as invasive pathogens, senescent proteins, and organelles. It can promote or suppress tumor development, so it is a "double-edged sword" in tumors that depends on the cell and tissue typ...

    journal_title：Molecular cancer

    pub_type： 杂志文章,评审

    doi：10.1186/s12943-019-1030-2

    authors： Chen HT,Liu H,Mao MJ,Tan Y,Mo XQ,Meng XJ,Cao MT,Zhong CY,Liu Y,Shan H,Jiang GM

    更新日期：2019-05-24 00:00:00

  • Malignancy-associated metabolic profiling of human glioma cell lines using 1H NMR spectroscopy.

    abstract：BACKGROUND:Ambiguity in malignant transformation of glioma has made prognostic diagnosis very challenging. Tumor malignant transformation is closely correlated with specific alterations of the metabolic profile. Exploration of the underlying metabolic alterations in glioma cells of different malignant degree is therefo...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-197

    authors： Shao W,Gu J,Huang C,Liu D,Huang H,Huang Z,Lin Z,Yang W,Liu K,Lin D,Ji T

    更新日期：2014-08-27 00:00:00

  • Targeting the Transforming Growth Factor-beta pathway inhibits human basal-like breast cancer metastasis.

    abstract：BACKGROUND:Transforming Growth Factor beta (TGF-beta) plays an important role in tumor invasion and metastasis. We set out to investigate the possible clinical utility of TGF-beta antagonists in a human metastatic basal-like breast cancer model. We examined the effects of two types of the TGF-beta pathway antagonists (...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-122

    authors： Ganapathy V,Ge R,Grazioli A,Xie W,Banach-Petrosky W,Kang Y,Lonning S,McPherson J,Yingling JM,Biswas S,Mundy GR,Reiss M

    更新日期：2010-05-26 00:00:00

  • ISL-1 is overexpressed in non-Hodgkin lymphoma and promotes lymphoma cell proliferation by forming a p-STAT3/p-c-Jun/ISL-1 complex.

    abstract：BACKGROUND:Insulin enhancer binding protein-1 (ISL-1), a LIM-homeodomain transcription factor, is essential for the heart, motor neuron and pancreas development. Recently, ISL-1 has been found in some types of human cancers. However, how ISL-1 exerts the role in tumor development is not clear. METHODS AND RESULTS:The ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-13-181

    authors： Zhang Q,Yang Z,Jia Z,Liu C,Guo C,Lu H,Chen P,Ma K,Wang W,Zhou C

    更新日期：2014-07-29 00:00:00

  • The Runx transcriptional co-activator, CBFbeta, is essential for invasion of breast cancer cells.

    abstract：BACKGROUND:The transcription factor Runx2 has an established role in cancers that metastasize to bone. In metastatic breast cancer cells Runx2 is overexpressed and contributes to the invasive capacity of the cells by regulating the expression of several invasion genes. CBFbeta is a transcriptional co-activator that is ...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-9-171

    authors： Mendoza-Villanueva D,Deng W,Lopez-Camacho C,Shore P

    更新日期：2010-06-30 00:00:00

  • Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.

    abstract：BACKGROUND:Epigenetic control is essential for maintenance of tissue hierarchy and correct differentiation. In cancer, this hierarchical structure is altered and epigenetic control deregulated, but the relationship between these two phenomena is still unclear. CD133 is a marker for adult stem cells in various tissues a...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/1476-4598-10-94

    authors： Pellacani D,Packer RJ,Frame FM,Oldridge EE,Berry PA,Labarthe MC,Stower MJ,Simms MS,Collins AT,Maitland NJ

    更新日期：2011-07-29 00:00:00

  • Nuclear-enriched abundant transcript 1 as a diagnostic and prognostic biomarker in colorectal cancer.

    abstract：BACKGROUND:High expression of the long non-coding RNA nuclear-enriched abundant transcript 1 (NEAT1) in whole blood has been reported in colorectal cancer patients; however, its' clinical significance and origin are unclear. We evaluated the diagnostic and prognostic value, and origin of whole blood NEAT1 in colorectal...

    journal_title：Molecular cancer

    pub_type： 杂志文章

    doi：10.1186/s12943-015-0455-5

    authors： Wu Y,Yang L,Zhao J,Li C,Nie J,Liu F,Zhuo C,Zheng Y,Li B,Wang Z,Xu Y

    更新日期：2015-11-09 00:00:00